Changeflow GovPing Healthcare & Life Sciences Substituted Indole Compounds With Inhibitory Ac...
Routine Rule Added Final

Substituted Indole Compounds With Inhibitory Activity for Treating Acute Renal Failure

Favicon for changeflow.com USPTO Patent Grants - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO granted patent US12606557B2 to the University of Pittsburgh-of the Commonwealth System of Higher Education on April 21, 2026. The patent covers substituted indole compounds and compositions for treating or preventing acute renal failure, as well as infectious diseases and cancer. The application (No. 17927406) was filed on May 27, 2021, with 17 claims and CPC classification C07D 471/04.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

USPTO issued patent US12606557B2 to the University of Pittsburgh, conferring exclusive rights to substituted indole compounds and compositions for therapeutic use. The patent lists five inventors and covers methods of treating acute renal failure, infectious diseases, and cancer using the claimed compounds.

Pharmaceutical and biotechnology companies developing treatments for renal disease, infectious diseases, or oncology should monitor this intellectual property landscape. The patent may affect freedom-to-operate analyses for related therapeutic programs, and companies with competing or complementary indole-based compounds should evaluate potential licensing or design-around strategies.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Grants

Substituted indoles with inhibitory activity

Grant US12606557B2 Kind: B2 Apr 21, 2026

Assignee

UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

Inventors

Donna Huryn, Neil Hukriede, Keith Long, Jagannath Panda, Sipak Joyasawal

Abstract

Disclosed are substituted indole compounds and compositions. The substituted indole compounds and compositions can be used for treating or preventing acute renal failure in a subject. The compounds and compositions can also be used for treating an infectious disease or cancer.

CPC Classifications

C07D 471/04

Filing Date

2021-05-27

Application No.

17927406

Claims

17

View original document →

Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 21st, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Research institutions Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent issuance Therapeutic compound development Intellectual property protection
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!